The current institutional shareholding score of Cardiff Oncology Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 35.32%, representing a quarter-over-quarter decrease of 33.21%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.15% of shares outstanding, with 1.28% increase in holdings.